• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估高血压患者中脂蛋白(a)水平与血压之间的关系,超越传统措施。一项观察性研究。

Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study.

机构信息

Department of Internal Medicine, University Hospital of Santiago de Compostela, A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain.

Health Research Institute of Santiago de Compostela (IDIS), A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain.

出版信息

Sci Rep. 2024 Jun 23;14(1):14433. doi: 10.1038/s41598-024-65231-w.

DOI:10.1038/s41598-024-65231-w
PMID:38910182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11194270/
Abstract

High lipoprotein(a) (Lp(a)) levels are associated with an increased risk of arterial hypertension (AHT) and atherosclerotic cardiovascular disease. However, little is known about the detailed profile of AHT based on Lp(a) levels. This observational study focused on elucidating the relationship between Lp(a) concentrations and specific indices obtained from 24-h ambulatory blood pressure (BP) monitoring in hypertensive patients over 18 years of age. We gathered and analyzed data on BP indices along with demographic, epidemiological, clinical, and laboratory variables from 227 hypertensive patients, median age 56 years, including 127 women (56%). After comparing hypertensive patients with Lp(a) levels above and below 125 nmol/L, we found that a 10 mmHg increase in nocturnal systolic BP and all pulse pressure indices (24-h, daytime, and night-time) was associated with an increased risk of high Lp(a) levels by more than 20% and 40%, respectively. Similarly, each 10% increase in the area under the function over time of nocturnal diastolic BP dipping was associated with more than a 30% decrease in the odds of belonging to the elevated Lp(a) levels category. Additionally, Lp(a) levels above 125 nmol/L were associated with higher 24-h, daytime, and night-time systolic BP and pulse pressure load. The relationship between Lp(a) and AHT appears to extend beyond conventional BP measurements, which may be relevant given the prognostic implications of nocturnal BP and pulse pressure indices.

摘要

脂蛋白(a)(Lp(a))水平升高与动脉高血压(AHT)和动脉粥样硬化性心血管疾病风险增加有关。然而,对于基于 Lp(a)水平的 AHT 详细特征知之甚少。这项观察性研究集中于阐明 Lp(a)浓度与 24 小时动态血压监测中高血压患者特定指数之间的关系。我们收集并分析了 227 名年龄在 18 岁以上的高血压患者的血压指数以及人口统计学、流行病学、临床和实验室变量的数据,这些患者的中位年龄为 56 岁,其中包括 127 名女性(56%)。在比较 Lp(a)水平高于和低于 125nmol/L 的高血压患者后,我们发现夜间收缩压和所有脉压指数(24 小时、白天和夜间)每增加 10mmHg,Lp(a)水平升高的风险分别增加超过 20%和 40%。同样,夜间舒张压下降功能时间下面积每增加 10%,属于 Lp(a)水平升高类别的几率就会降低超过 30%。此外,Lp(a)水平高于 125nmol/L 与 24 小时、白天和夜间收缩压和脉压负荷增加有关。Lp(a)与 AHT 的关系似乎超出了常规血压测量范围,鉴于夜间血压和脉压指数的预后意义,这可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/001b6331f029/41598_2024_65231_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/f709084822f3/41598_2024_65231_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/21d5d8336b2a/41598_2024_65231_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/001b6331f029/41598_2024_65231_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/f709084822f3/41598_2024_65231_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/21d5d8336b2a/41598_2024_65231_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/11194270/001b6331f029/41598_2024_65231_Fig3_HTML.jpg

相似文献

1
Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study.评估高血压患者中脂蛋白(a)水平与血压之间的关系,超越传统措施。一项观察性研究。
Sci Rep. 2024 Jun 23;14(1):14433. doi: 10.1038/s41598-024-65231-w.
2
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.动态血压状况、动态血压控制、心血管疾病和肾脏疾病进展:一项慢性肾脏病多中心队列研究
Am J Kidney Dis. 2023 Jan;81(1):15-24.e1. doi: 10.1053/j.ajkd.2022.04.010. Epub 2022 Jun 13.
3
Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.伴有和不伴有 2 型糖尿病的高血压患者的动态血压昼夜节律。
Chronobiol Int. 2013 Mar;30(1-2):99-115. doi: 10.3109/07420528.2012.701489. Epub 2012 Oct 25.
4
Ambulatory Arterial Stiffness Index (AASI) is Unable to Estimate Arterial Stiffness of Hypertensive Subjects: Role of Nocturnal Dipping of Blood Pressure.动态动脉僵硬度指数(AASI)无法评估高血压患者的动脉僵硬度:夜间血压波动的作用
Curr Hypertens Rev. 2017;13(2):121-131. doi: 10.2174/1573402113666170621110305.
5
Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.比较有和无慢性肾脏病的高血压患者的动态血压参数。
Chronobiol Int. 2013 Mar;30(1-2):145-58. doi: 10.3109/07420528.2012.703083. Epub 2012 Oct 25.
6
The relationship between serum albumin levels and 24-h ambulatory blood pressure monitoring recordings in non-diabetic essential hypertensive patients.非糖尿病原发性高血压患者血清白蛋白水平与24小时动态血压监测记录之间的关系。
Clinics (Sao Paulo). 2016 May;71(5):257-63. doi: 10.6061/clinics/2016(05)03.
7
Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension.原发性高血压患者中脂蛋白(a)水平、氧化应激与血压水平之间的关系。
Clin Exp Med. 2001 Sep;1(3):145-50. doi: 10.1007/s10238-001-8026-z.
8
[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].[原发性高血压患者治疗后昼夜血压及影响因素分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4.
9
Diurnal rhythm of blood pressure among Nigerians with hypertension using 24-hour ambulatory blood pressure monitoring.尼日利亚高血压患者使用 24 小时动态血压监测的血压昼夜节律。
Pan Afr Med J. 2020 Aug 4;36:240. doi: 10.11604/pamj.2020.36.240.24088. eCollection 2020.
10
Nocturnal blood pressure rather than night-to-day blood pressure ratio is related to arterial stiffening in untreated young and middle-aged adults with non-dipper hypertension.未经治疗的非杓型高血压中青年人群中,夜间血压而非夜间与日间血压比值与动脉僵硬度相关。
J Clin Hypertens (Greenwich). 2022 Aug;24(8):1044-1050. doi: 10.1111/jch.14546. Epub 2022 Jul 27.

引用本文的文献

1
Evaluating an Early Risk Model for Uncomplicated Hypertension in Pregnancy Based on Nighttime Blood Pressure, Uric Acid, and Angiogenesis-Related Factors.基于夜间血压、尿酸及血管生成相关因子评估妊娠期单纯性高血压的早期风险模型
Int J Mol Sci. 2025 Jun 25;26(13):6115. doi: 10.3390/ijms26136115.
2
Lipoprotein(a) and panvascular disease.脂蛋白(a)与泛血管疾病。
Lipids Health Dis. 2025 May 24;24(1):186. doi: 10.1186/s12944-025-02600-y.
3
Assessing the relationship between short-term blood pressure variability and glycation profile in young and middle-aged nondiabetic hypertensive individuals.

本文引用的文献

1
The Role of Blood Pressure Load in Ambulatory Blood Pressure Monitoring in Adults: A Literature Review of Current Evidence.血压负荷在成人动态血压监测中的作用:当前证据的文献综述
Diagnostics (Basel). 2023 Jul 26;13(15):2485. doi: 10.3390/diagnostics13152485.
2
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
3
评估年轻及中年非糖尿病高血压个体的短期血压变异性与糖化指标之间的关系。
J Hypertens. 2025 Jul 1;43(7):1148-1157. doi: 10.1097/HJH.0000000000004029. Epub 2025 Apr 21.
4
Lipoprotein(a) among normotensive patients and risk of incident hypertension.血压正常患者的脂蛋白(a)与新发高血压风险。
J Clin Hypertens (Greenwich). 2024 Nov;26(11):1313-1317. doi: 10.1111/jch.14904. Epub 2024 Sep 14.
Association of a Novel Homozygous Variant in Gene with Tangier Disease.基因中的一种新型纯合变异与Tangier病的关联。
J Clin Med. 2023 Mar 30;12(7):2596. doi: 10.3390/jcm12072596.
4
The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease.甘油三酯/高密度脂蛋白胆固醇(TG/HDL-C)比值作为代谢综合征和心血管疾病的风险标志物
Diagnostics (Basel). 2023 Mar 1;13(5):929. doi: 10.3390/diagnostics13050929.
5
Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure.钠-葡萄糖协同转运蛋白2抑制剂对血压的多效性作用
Front Cardiovasc Med. 2022 Dec 20;9:1086672. doi: 10.3389/fcvm.2022.1086672. eCollection 2022.
6
Correlation between Blunted Nocturnal Decrease in Diastolic Blood Pressure and Oxidative Stress: An Observational Study.夜间舒张压下降减弱与氧化应激之间的相关性:一项观察性研究。
Antioxidants (Basel). 2022 Dec 9;11(12):2430. doi: 10.3390/antiox11122430.
7
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
8
Circulating lipoprotein(a) levels and health outcomes: Phenome-wide Mendelian randomization and disease-trajectory analyses.循环脂蛋白(a)水平与健康结局:表型全基因组 Mendelian 随机化和疾病轨迹分析。
Metabolism. 2022 Dec;137:155347. doi: 10.1016/j.metabol.2022.155347. Epub 2022 Nov 15.
9
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.糖尿病患者的收缩压累计负荷与心血管风险。
J Am Coll Cardiol. 2022 Sep 20;80(12):1147-1155. doi: 10.1016/j.jacc.2022.06.039.
10
Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease.脂蛋白(a)水平中度升高与复发性心血管疾病患者更早需要进行经皮冠状动脉介入治疗有关。
Exp Ther Med. 2022 May 13;24(1):444. doi: 10.3892/etm.2022.11371. eCollection 2022 Jul.